Revenue Growth
Net sales of $124.0M in Q1 2026, up ~7% versus $116.0M in Q1 2025, driven primarily by U.S. businesses.
U.S. Crop Strength
U.S. crop sales increased 17% year-over-year driven by strong herbicide and insecticide demand (notably Impact and Aztec); volume was the main driver of the increase.
Specialty Business Improvement
Specialty sales grew ~6% year-over-year, led by OHP horticultural products and increased demand for biological solutions.
Significant EBITDA and Margin Expansion
Adjusted EBITDA rose to $10.3M in Q1 2026, up ~245% from $3M a year ago. Gross profit margin improved to 31% from 26% (a ~500 basis point increase).
Operating Efficiency and Cost Controls
Adjusted operating expenses improved to 26.7% of sales from 27.9% a year ago; company highlighted manufacturing rationalization (shift from L.A. to Axis, AL) with expected annualized savings of at least $4M.
Stronger Liquidity Position
Cash on hand increased to $71M from $12M year-over-year due to refinancing/term loan structure, providing a liquidity cushion while enabling strategic execution.
Inventory and SIOP Improvements
Inventories decreased to $175M from $185M year-over-year (improvement of $10M), reflecting improved supply chain discipline and sales/inventory/operations planning (SIOP) progress.
Medium- and Long-Term Targets
Management reiterated 2026 guidance of adjusted EBITDA $44M–$48M on sales of $530M–$550M; longer-term goals include >$600M revenue by 2028 (~20% above 2025) and a long-term target near 15% EBITDA margins, plus a plan for 50 new product launches over five years to drive $100M annualized revenue by 2030.